citiusonc.com - CTOR Net Assets per Single Share

Public company logo of Citius Oncology Inc. (CTOR)

This daily price chart for Citius Oncology, Inc. (CTOR) reflects the price action of an asset currently valued at 0.38. The business does not generate sales, as it directs resources toward drug trials, resulting in losses. Citius Oncology, Inc. (CTOR) develops targeted molecules for precision tumor destruction. Growth prospects rely on alliances with biotech behemoths to bring new lymphoma therapies to market.

Citius Oncology Inc. (CTOR) - Accounting Value per Share from 08/14/2024 to 10/28/2026

Summary analytical data breakdowns for citiusonc.com (CTOR)

- price and consensus price forecast:
Price Chart Citius Oncology, Inc|CTOR - Average Forecast Price
- market capitalization data:
Market Value Citius Oncology, Inc.|CTOR - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share Citius Oncology|CTOR - Company Net Assets|Market Capitalization to Book Value Ratio citiusonc.com|CTOR - Company Total Assets
- debt and liquidity data:
Debt to Equity Citius Oncology, Inc.|CTOR - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Citius Oncology|CTOR - Company Total Debt|Debts to Book Capitalization Citius Oncology, Inc.|CTOR - Long-Term Debt|Company Short-Term Debt Citius Oncology
Analysis of all company metrics:Citius Oncology, Inc, CTOR
Manufactured product of citiusonc.com

This indicator is calculated as the difference between the company's total assets and all liabilities, divided by the number of shares outstanding, which determines the actual value of an investor's stake upon business liquidation. The book value per share trend for Citius Oncology, Inc. (CTOR) allows for an assessment of the issuer's financial stability during the period leading up to the final regulatory approval of its T-cell lymphoma drug.

Competitor analysis for Citius Oncology, Inc.

ONC (BeiGene Corp) - Net Assets per Single Share|HALO: Net Asset Value per Share|Net Assets per Single Share Revolution Medicines RVMD|ascentage.com (AAPG) - Accounting Value of a Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|TuHURA Biosciences, Inc. (HURA) - Accounting Value per Share|Accounting Value of a Share Protara Therapeutics Inc (TARA)|Fate Therapeutics Corp - Book Value per Share|WHWK - Accounting Value per Share|TScan - Accounting Value per Share|CSBR: Book Value per Share|Net Assets per Single Share xbiotech.com XBIT|CEL-SCI (CVM) - Accounting Value of a Share|Book Value per Share OSTX (OS Therapies Inc)|Net Asset Value per Share radiopharmtheranostics.com|Book Value per Share ARTV (Artiva Biotherapeutics, Inc.)|Accounting Value per Share adlainortye.com (ANL)|Book Value per Share VERU|TPST - Net Assets per Share|Accounting Value per Share Xilio XLO|RENB - Book Price of a Share|muraloncology.com - Book Value per Share|Net Assets per Share Kairos Pharma|OKUR (OnKure Therapeutics, Inc.) - Accounting Value per Share|Book Value per Share GDTC|CRIS (Curis, Inc.) - Net Assets per Single Share|Net Assets per Share apollomicsinc.com APLM|Accounting Value per Share Tharimmune, Inc.|Advanced Biomed Inc. - Accounting Value of a Share|GNPX (Genprex) - Net Assets per Single Share|CLDI: Net Asset Value per Share|Net Assets per Single Share Sunshine Biopharma, Inc.|Xenetic Biosciences, Inc. (XBIO) - Equity per Share|Book Value per Share SLRX|Accounting Value per Share PPBT|American Oncology Network - Net Assets per Single Share|Net Asset Value per Share BGNE (BeiGene Ltd.)|Net Assets per Single Share Checkpoint Therapeutics, Inc CKPT|elevationoncology.com - Net Assets per Single Share|ICAD (iCAD Corp) - Net Assets per Single Share|IKNA - Net Asset Value per Share|Book Value per Share NTBL (Notable Labs)|Book Value of One Share Viracta Therapeutics, Inc.|Accounting Value per Share MOR (MorphoSys Corp)|Net Asset Value per Share NAYA Biosciences Corp (NAYA)|Ascentage Pharma Group (AAPGV) - Accounting Value per Share